NBIX · Neurocrine Biosciences Inc · Investor Relations
$143.29
+1.98 (+1.40%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$14.36B
Shares
101.65M
Volume · Oct 22
1.24M
Avg daily vol (3M)
1.31M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-02 00:00 UTC | Neurocrine Biosciences Q3 2026 Financial Results | Earnings call |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference 2026 | Conference |
| 2026-09-09 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-07-30 | Neurocrine Biosciences Conference Call and Webcast of Q2 2026 Financial Results | Earnings call |
| 2026-05-26 | Neurocrine Biosciences to Present at the William Blair 46th Annual Growth Stock Conference | Conference |
| 2026-05-26 | Neurocrine Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-05 | Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results | Earnings call |
| 2026-05-05 | Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026 | Conference |
| 2026-02-11 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.neurocrine.com/
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
132 filings
123 filers
Visit website
Investor relations